Sign in

CIK 0001129928

  • Non-accelerated filer
  • Smaller reporting company

ONCOLYTICS BIOTECH INC

Sign in to watch
Ticker
ONCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
980541667
Phone
+1 403-670-7377
Business address
SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
  1. 4 Open-market buy Director bought 30,000 shares at $0.84 ($25,338)
  2. 4 Open-market buy Chief Medical Officer bought 12,132 shares at $0.83 ($10,033)
  3. 4 Open-market buy Director bought 25,000 shares at $0.85 ($21,240)
  4. 4 Open-market buy VP, Product Development bought 10,000 shares at $0.83 ($8,298)
  5. 4 Open-market buy Director bought 100,000 shares at an average $0.83 ($83,454)
  6. 4 Open-market buy Chief Business Officer bought 29,600 shares at $0.86 ($25,418)
  7. 4 Open-market buy Director bought 35,400 shares at $0.86 ($30,292)
  8. 4 Open-market buy Director bought 100,000 shares at $1.04 ($103,770)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 2 · 40 filings